Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Regulation of CK2 by phosphorylation and O-GlcNAcylation revealed by semisynthesis.

Mary Katherine Tarrant | Hee-Sool Rho | Zhi Xie | Yu Lin Jiang | Christopher Gross | Jeffrey C Culhane | Gai Yan | Jiang Qian | Yoshitaka Ichikawa | Tatsuji Matsuoka | Natasha Zachara | Felicia A Etzkorn | Gerald W Hart | Jun Seop Jeong | Seth Blackshaw | Heng Zhu | Philip A Cole
Nature chemical biology | 2012

Protein serine-threonine kinase casein kinase II (CK2) is involved in a myriad of cellular processes including cell growth and proliferation through its phosphorylation of hundreds of substrates, yet how CK2 function is regulated is poorly understood. Here we report that the CK2 catalytic subunit CK2α is modified by O-linked β-N-acetyl-glucosamine (O-GlcNAc) on Ser347, proximal to a cyclin-dependent kinase phosphorylation site (Thr344). We use protein semisynthesis to show that phosphorylation of Thr344 increases the cellular stability of CK2α by strengthening its interaction with Pin1, whereas glycosylation of Ser347 seems to be antagonistic to Thr344 phosphorylation and permissive to proteasomal degradation. By performing kinase assays with site-specifically phospho- and glyco-modified CK2α in combination with CK2β and Pin1 binding partners on human protein microarrays, we show that the kinase substrate selectivity of CK2 is modulated by these specific post-translational modifications. This study suggests how a promiscuous protein kinase can be regulated at multiple levels to achieve particular biological outputs.

Pubmed ID: 22267120

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NCRR NIH HHS, United States
    Id: U54 RR020839
  • Agency: NCI NIH HHS, United States
    Id: R29 CA074305
  • Agency: NIGMS NIH HHS, United States
    Id: R37 GM062437
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK079637
  • Agency: NCI NIH HHS, United States
    Id: CA42486
  • Agency: NCI NIH HHS, United States
    Id: R01 CA042486
  • Agency: NCRR NIH HHS, United States
    Id: RR020839
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM062437
  • Agency: NHLBI NIH HHS, United States
    Id: P01 HL107153
  • Agency: NIGMS NIH HHS, United States
    Id: GM62437
  • Agency: NCI NIH HHS, United States
    Id: R29 CA074305-06

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Covance (tool)

RRID:SCR_001224

A contract research organization providing drug development and animal testing services. Under the name Covance Research Products Inc., based in Denver, Pennsylvania, the company also deals in the import, breeding and sale of laboratory animals. It breeds dogs, rabbits, guinea pigs, non-human primates, and pigs, and runs the largest non-human primate laboratory in Germany. (Wikipedia)

View all literature mentions

HeLa (tool)

RRID:CVCL_0030

Cell line HeLa is a Cancer cell line with a species of origin Homo sapiens

View all literature mentions